Literature DB >> 8325022

Follow-up evaluation of the first patients with IgA nephropathy described at Necker Hospital.

D Chauveau1, D Droz.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8325022     DOI： 10.1159/000422388

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  16 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  Selective expansion of T cell receptor (TCR) V beta 6 in tonsillar and peripheral blood T cells and its induction by in vitro stimulation with Haemophilus parainfluenzae in patients with IgA nephropathy.

Authors:  H Nozawa; M Takahara; T Yoshizaki; T Goto; N Bandoh; Y Harabuchi
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

3.  Epidemiological survey and clinical investigation of pediatric IgA nephropathy.

Authors:  Takayuki Shibano; Nobuaki Takagi; Kohei Maekawa; Hiromu Mae; Masuji Hattori; Yasuhiro Takeshima; Takakuni Tanizawa
Journal:  Clin Exp Nephrol       Date:  2015-06-04       Impact factor: 2.801

4.  Impact of the new risk stratification in the 2011 Japanese Society of Nephrology clinical guidelines for IgA nephropathy on incidence of early clinical remission with tonsillectomy plus steroid pulse therapy.

Authors:  Yoshikuni Nagayama; Hiroki Nishiwaki; Takeshi Hasegawa; Daisuke Komukai; Eri Kawashima; Mamiko Takayasu; Hironori Tayama; Yoshihiko Inoue; Kiyoko Inui; Ashio Yoshimura
Journal:  Clin Exp Nephrol       Date:  2014-11-07       Impact factor: 2.801

5.  Glomerular density in renal biopsy specimens predicts the long-term prognosis of IgA nephropathy.

Authors:  Nobuo Tsuboi; Tetsuya Kawamura; Kentaro Koike; Hideo Okonogi; Keita Hirano; Akihiko Hamaguchi; Yoichi Miyazaki; Makoto Ogura; Kensuke Joh; Yasunori Utsunomiya; Tatsuo Hosoya
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 8.237

6.  Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy.

Authors:  Naoto Miura; Hirokazu Imai; Shogo Kikuchi; Shogo Hayashi; Masayuki Endoh; Tetsuya Kawamura; Yasuhiko Tomino; Kumiko Moriwaki; Hideyasu Kiyomoto; Kentaro Kohagura; Eiko Nakazawa; Eiji Kusano; Toshio Mochizuki; Shinsuke Nomura; Tamaki Sasaki; Naoki Kashihara; Jun Soma; Tadashi Tomo; Iwao Nakabayashi; Masaharu Yoshida; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

7.  Clinicopathological characteristics of patients with immunoglobulin A nephropathy showing acute exacerbations after favorable long-term clinical courses.

Authors:  Mai Tanaka; Yoichi Miyazaki; Kentaro Koike; Hiroyuki Ueda; Nobuo Tsuboi; Keita Hirano; Hideo Okonogi; Makoto Ogura; Tetsuya Kawamura; Takashi Yokoo
Journal:  Clin Exp Nephrol       Date:  2015-08-20       Impact factor: 2.801

Review 8.  Treatment of IgA nephropathy.

Authors:  Claudio Pozzi
Journal:  J Nephrol       Date:  2015-11-17       Impact factor: 3.902

Review 9.  IgA glycosylation and immune complex formation in IgAN.

Authors:  Hitoshi Suzuki; Jan Novak
Journal:  Semin Immunopathol       Date:  2021-09-27       Impact factor: 9.623

10.  Expression of P311, a transforming growth factor beta latency-associated protein-binding protein, in human kidneys with IgA nephropathy.

Authors:  Fengping Wang; Xisheng Xie; Junming Fan; Li Wang; Dongyang Guo; Lichuan Yang; Xiaofen Ma; Lina Zhang; Zi Li
Journal:  Int Urol Nephrol       Date:  2009-11-28       Impact factor: 2.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.